CFDE Data Portal | Search LINC03015

	Label	Description
	LINC03015 Gene (Entity type)	ENSG00000242474 - long intergenic non-protein coding RNA 3015
	GSE216043 cisplatin 7 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE196343 metformin 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE238116 EGR1 HCC overexpression MHCC97-H PLC-PRF-5 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213588 trametinib NF1 9 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE198930 prunetin AGS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE99875 everolimus 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE102467 clofilium 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE140758 MDM2 inhibition 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC03015

ENSG00000242474 - long intergenic non-protein coding RNA 3015

GSE216043 cisplatin 7 v 0 human dn

A Gene Set from LINCS

GSE196343 metformin 1 v 0 human dn

A Gene Set from LINCS

GSE238116 EGR1 HCC overexpression MHCC97-H PLC-PRF-5 3 v 0 human up

A Gene Set from LINCS

GSE213588 trametinib NF1 9 v 11 human dn

A Gene Set from LINCS

GSE198930 prunetin AGS 1 v 0 human dn

A Gene Set from LINCS

GSE99875 everolimus 2 v 0 human dn

A Gene Set from LINCS

GSE102467 clofilium 3 v 0 human dn

A Gene Set from LINCS

GSE77108 saha 6 v 9 human up

A Gene Set from LINCS

GSE140758 MDM2 inhibition 4 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.